Literature DB >> 2855634

Synthesis and biodistribution of [11C]fludiazepam for imaging benzodiazepine receptors.

K Ishiwata1, K Yanai, T Ido, Y Miura-Kanno, K Kawashima.   

Abstract

As a tracer for in vivo studies on benzodiazepine receptors, 7-chloro-1,3-dihydro-5-(2-fluorophenyl)-1-[11C]methyl-2H-1,4- benzodiazepin-2-one, [11C]fludiazepam, was synthesized by the methylation of nor-derivative with [11C]CH3I, and purified by high-performance liquid chromatography. Within 60 min [11C]fludiazepam was obtained for injection in high radiochemical yields and in high radiochemical purity with a specific activity of up to 230 mCi/mumol. After i.v. injection of [11C]fludiazepam in rats the radioactivity was rapidly incorporated into many tissues and the blood clearance of the radioactivity was very rapid. The brain uptake was high and decreased gradually. The adrenal uptake was the highest and decreased with high loading doses. The effect of the loading dose on the uptake was also found in the heart and lungs. By autoradiography using [11C]fludiazepam, a higher accumulation was visualized in the cortex and thalamus than in other regions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2855634     DOI: 10.1016/0883-2897(88)90005-0

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN: 0883-2897


  2 in total

1.  11C-labeled 2'-iododiazepam for PET studies of benzodiazepine receptors: synthesis and comparison of biodistribution with its radioiodinated compound.

Authors:  Y Iida; H Saji; Y Magata; J Konishi; I Nakatsuka; A Yoshitake; A Yokoyama
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

2.  The Search for a Subtype-Selective PET Imaging Agent for the GABAA Receptor Complex: Evaluation of the Radiotracer [11C]ADO in Nonhuman Primates.

Authors:  Shu-Fei Lin; Frederic Bois; Daniel Holden; Nabeel Nabulsi; Richard Pracitto; Hong Gao; Michael Kapinos; Jo-Ku Teng; Anupama Shirali; Jim Ropchan; Richard E Carson; Charles S Elmore; Neil Vasdev; Yiyun Huang
Journal:  Mol Imaging       Date:  2017 Jan-Dec       Impact factor: 4.488

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.